Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.
Charles H Kellner, Rebecca Knapp, Mustafa M Husain...
https://pubmed.ncbi.nlm.nih.gov/20194546/Actively Recruiting
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-05-11
196
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating two different electrode positions for electroconvulsive therapy ECT in adults with difficult-to-treat depression who do not show early improvement during an acute ECT course. The trial aims to compare continuing right unilateral RUL ECT versus switching to bitemporal BT ECT to see which approach speeds recovery and has less impact on memory. The study also follows depressive symptoms and cognitive performance up to three months after treatment. Participants who do not respond after four ECT sessions are randomly assigned to either continue with RUL ECT or switch to BT ECT until remission is reached. Treatments are delivered using different electrode placements on the ECT device. Assessments occur at baseline, after four and eight ECT sessions, at the end of the acute course up to seven weeks, and three months later. During the study, mood and neurocognitive tests, including assessments of autobiographical memory and various cognitive performance measures, are performed at multiple time points. Researchers track changes in depressive symptoms and memory function to understand treatment effects. The trial includes monitoring up to three months post-treatment to observe recovery and cognitive outcomes.
CONDITIONS
Changing Tactics? Optimizing ECT in Difficult-to-treat Depression
P
Pascal Sienaert, MD,PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
Universiteit Antwerpen
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 7 weeks
Participants receive an acute course of electroconvulsive therapy (ECT) using either right unilateral (RUL) or bitemporal (BT) electrode positions. Participants showing no response to initial RUL ECT will be switched to BT ECT until remission is achieved.
Up to 8 ECT sessions over 4 weeks, continuing as needed until remission
Duration - 3 months post-acute course
Participants are monitored for depressive symptoms and cognitive function after completing the acute ECT course.
1 follow-up visit approximately 3 months after treatment
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Charles H Kellner, Rebecca Knapp, Mustafa M Husain...
https://pubmed.ncbi.nlm.nih.gov/20194546/C H Kellner, J Obbels, P Sienaert
https://pubmed.ncbi.nlm.nih.gov/31774547/Maria Semkovska, Sabine Landau, Ross Dunne...
https://pubmed.ncbi.nlm.nih.gov/26892939/A J Rush, C M Gullion, M R Basco...
https://pubmed.ncbi.nlm.nih.gov/8733206/A John Rush, Madhukar H Trivedi, Stephen R Wisniewski...
https://pubmed.ncbi.nlm.nih.gov/17074942/Charles H Kellner, Rebecca G Knapp, Georgios Petrides...
https://pubmed.ncbi.nlm.nih.gov/17146008/Charles H Kellner, Mustafa M Husain, Rebecca G Knapp...
https://pubmed.ncbi.nlm.nih.gov/27418379/H A Sackeim, P Decina, M Kanzler...
https://pubmed.ncbi.nlm.nih.gov/3314538/Maria Semkovska, Declan M McLoughlin
https://pubmed.ncbi.nlm.nih.gov/20673880/T K Birkenhager, J Roos, A M Kamperman
https://pubmed.ncbi.nlm.nih.gov/31104321/Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
Universiteit Antwerpen
Collaborating Sponsor